INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
SL
Corporate insider

Sing George L

DirectorCIK 0001225471

EDGAR filingsOpen in network
Disclosed transactions13
Buys / sells0 / 9
Max Insider Score53
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
49
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$4.18M
4,338 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    REGENERON PHARMACEUTICALS, INC.Director · Form 144 · Nov 1, 2026
49
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL
$2.58M
2,670 sh
Nov 2, 2026
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

49
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.47M
1,522 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

9
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
7,830 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

9
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
7,439 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

42
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$519K
540 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

39
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$194K
200 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

45
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.01M
1,040 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

45
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.18M
1,224 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

26
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$2.95M
7,830 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

22
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$2.83M
7,439 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

49
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$2.43M
2,522 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

53
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$6.83M
7,073 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence